Evidence map›Paper›PMID 26309811›Full record

ArticleCurrent opinion in chemical engineering2015

In silico model-based inference: an emerging approach for inverse problems in engineering better medicines.

David J Klinke, Marc R Birtwistle

Abstract read
In one paragraph

Article in Current opinion in chemical engineering, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

David J KlinkeDepartment of Chemical Engineering and Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, WV ; Department of Microbiology, Immunology, & Cell Biology, West Virginia University, Morgantown, WV.
Marc R BirtwistleDepartment of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, New York, NY.

Funding

System Biology Center in New YorkP50GM071558 · NIGMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI IYENGAR, SRINIVAS RAVI V · 2007 to 2017
$22.8M
Drug Combination Signatures for Prediction and Mitigation of ToxicityU54HG008098 · NHGRI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BIRTWISTLE, MARC R., SOBIE, ERIC A · 2014 to 2019
$11.8M
Predicting the Heterogeneity of Cell-Fate DecisionsR01GM104184 · NIGMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BIRTWISTLE, MARC R. · 2014 to 2018
$1.8M
Noncanonical signaling and Emergent Trastuzumab Resistance in Breast CancerR15CA132124 · NCI · WEST VIRGINIA UNIVERSITY · PI KLINKE, DAVID JOHN · 2009 to 2012
$752k
NCI NIH HHS R15 CA132124NHGRI NIH HHS U54 HG008098NIGMS NIH HHS P50 GM071558NIGMS NIH HHS R01 GM104184
6 · The paper itself

Abstract

Identifying the network of biochemical interactions that underpin disease pathophysiology is a key hurdle in drug discovery. While many components involved in these biological processes are identified, how components organize differently in health and disease remains unclear. In chemical engineering, mechanistic modeling provides a quantitative framework to capture our understanding of a reactive system and test this knowledge against data. Here, we describe an emerging approach to test this knowledge against data that leverages concepts from probability, Bayesian statistics, and chemical kinetics by focusing on two related inverse problems. The first problem is to identify the causal structure of the reaction network, given uncertainty as to how the reactive components interact. The second problem is to identify the values of the model parameters, when a network is known a priori.

Indexed as

inverse problemsJAK-STAT signaling pathwaysMarkov Chain Monte Carlo methodsquantitative and systems pharmacology

Identifiers

PMID26309811
PMCPMC4545575

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.